BR112015025042B1 - Sistema de diagnóstico e método para detectar vírus influenza, composto inibidor de máscara e kit - Google Patents
Sistema de diagnóstico e método para detectar vírus influenza, composto inibidor de máscara e kit Download PDFInfo
- Publication number
- BR112015025042B1 BR112015025042B1 BR112015025042-4A BR112015025042A BR112015025042B1 BR 112015025042 B1 BR112015025042 B1 BR 112015025042B1 BR 112015025042 A BR112015025042 A BR 112015025042A BR 112015025042 B1 BR112015025042 B1 BR 112015025042B1
- Authority
- BR
- Brazil
- Prior art keywords
- neuraminidase
- sample
- influenza
- test
- assay
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361807185P | 2013-04-01 | 2013-04-01 | |
| US61/807,185 | 2013-04-01 | ||
| PCT/US2014/032567 WO2014165536A1 (en) | 2013-04-01 | 2014-04-01 | Methods and kits for the diagnosis of influenza |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015025042A2 BR112015025042A2 (https=) | 2017-09-05 |
| BR112015025042B1 true BR112015025042B1 (pt) | 2023-11-14 |
Family
ID=50625220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015025042-4A BR112015025042B1 (pt) | 2013-04-01 | 2014-04-01 | Sistema de diagnóstico e método para detectar vírus influenza, composto inibidor de máscara e kit |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10317404B2 (https=) |
| EP (1) | EP2981618B1 (https=) |
| JP (2) | JP6591398B2 (https=) |
| KR (1) | KR102348484B1 (https=) |
| CN (2) | CN105264086B (https=) |
| AU (2) | AU2014248225B2 (https=) |
| BR (1) | BR112015025042B1 (https=) |
| CA (1) | CA2908028C (https=) |
| ES (1) | ES2754402T3 (https=) |
| RU (1) | RU2713112C2 (https=) |
| WO (1) | WO2014165536A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6411740B2 (ja) * | 2013-01-15 | 2018-10-24 | 国立大学法人広島大学 | ノイラミニダーゼ活性阻害剤の有効性を判定するための組成物、キットおよびその利用 |
| WO2014165536A1 (en) | 2013-04-01 | 2014-10-09 | Becton, Dickinson And Company | Methods and kits for the diagnosis of influenza |
| US10520498B2 (en) | 2017-03-14 | 2019-12-31 | Becton, Dickinson And Company | Devices and techniques for oral fluid collection and seroprotection testing |
| BR112019027993A2 (pt) * | 2017-07-04 | 2020-07-07 | Cavidi Ab | métodos para avaliar a susceptibilidade de um vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, para avaliar se um paciente tratado para uma infecção viral tem necessidade de alterar a terapia farmacológica com um fármaco inibidor da enzima viral e para determinar a carga de um vírus em uma amostra do paciente e a dita resistência do vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, e, sistema |
| US11391748B2 (en) * | 2017-09-21 | 2022-07-19 | Becton, Dickinson And Company | High dynamic range assays in hazardous contaminant testing |
| JP7206257B2 (ja) | 2017-09-21 | 2023-01-17 | ベクトン・ディキンソン・アンド・カンパニー | 危険汚染物質の収集キット及び迅速試験 |
| CA3075769A1 (en) * | 2017-09-21 | 2019-03-28 | Becton, Dickinson And Company | Sampling systems and techniques to collect hazardous contaminants with high pickup and shedding efficiencies |
| US11002642B2 (en) | 2017-09-21 | 2021-05-11 | Becton, Dickinson And Company | Demarcation template for hazardous contaminant testing |
| WO2019060269A1 (en) * | 2017-09-21 | 2019-03-28 | Becton, Dickinson And Company | KIT FOR COLLECTING HAZARDOUS CONTAMINANTS AND RAPID ANALYSIS |
| EP3684512B1 (en) | 2017-09-21 | 2025-07-23 | Becton, Dickinson and Company | Augmented reality devices for hazardous contaminant testing |
| EP3685139B1 (en) | 2017-09-21 | 2023-12-13 | Becton, Dickinson and Company | Reactive demarcation template and method for hazardous contaminant testing |
| US11324219B2 (en) * | 2018-03-02 | 2022-05-10 | Nihon Nohyaku Co., Ltd. | Amide compound or salt thereof, agricultural and horticultural microbicide comprising the compound and the salt, and method for using the agricultural and horticultural microbicide |
| KR102129937B1 (ko) | 2018-07-31 | 2020-07-03 | 재단법인 아산사회복지재단 | 종이기반 핵산검출용 키트 및 pcr 증폭산물을 분석하기 위한 방법 |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| CA3125355A1 (en) | 2019-01-28 | 2020-08-06 | Becton, Dickinson And Company | Hazardous contaminant collection device with integrated swab and test device |
| CN113614534A (zh) * | 2019-03-25 | 2021-11-05 | 积水医疗株式会社 | 呼吸道病毒的免疫测定方法和检测试剂盒 |
| KR20230048505A (ko) * | 2020-06-15 | 2023-04-11 | 뉴옴 펩타이즈 피티이. 엘티디. | 분석물의 검출을 위한 측면 유동 검정 장치 및 이의 검출 방법 |
| JP2022018768A (ja) * | 2020-07-16 | 2022-01-27 | デンカ株式会社 | 簡易鼻腔粘膜表面付着粘液の採取方法および該検体中の被検出物を検出するための検査キット |
| KR20220060269A (ko) | 2020-11-04 | 2022-05-11 | 인텔로스 주식회사 | 코로나 바이러스 감염증 및 인플루엔자 바이러스 감염증 동시 진단키트 |
| KR102265441B1 (ko) * | 2020-12-23 | 2021-06-15 | 충남대학교 산학협력단 | 화학 발광 기반의 조류 인플루엔자 바이러스 검출용 조성물 및 이의 용도 |
| CN115015541A (zh) | 2021-03-05 | 2022-09-06 | 全球诊断系统受益有限责任公司 | 带流体贮存器的诊断装置及相关方法和试剂盒 |
| JP2023016530A (ja) * | 2021-07-21 | 2023-02-02 | 東洋紡株式会社 | イムノクロマト試験片 |
| JP2023016529A (ja) * | 2021-07-21 | 2023-02-02 | 東洋紡株式会社 | イムノクロマト試験片 |
| US20250066867A1 (en) * | 2023-08-23 | 2025-02-27 | Vedabio, Inc. | Rapid detection of known and emerging influenza viruses |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4590169A (en) | 1983-11-18 | 1986-05-20 | Beckman Instruments, Inc. | Direct particle agglutination immunoassays avoiding false negatives at high antigen concentrations |
| US4810631A (en) | 1986-05-12 | 1989-03-07 | Becton, Dickinson And Company | Signal enhancement in immunoassay by modulation of chemical catalysis |
| US4835099A (en) | 1986-11-20 | 1989-05-30 | Becton, Dickinson And Company | Signal enhancement in immunoassay by modulation of enzymatic catalysis |
| US4904583A (en) | 1987-05-26 | 1990-02-27 | Becton, Dickinson And Company | Cascade immunoassay by multiple binding reactions |
| US5017473A (en) | 1987-05-26 | 1991-05-21 | Becton, Dickinson And Company | Homogeneous chemiluminescence immunoassay using a light absorbing material |
| CA2000678A1 (en) * | 1988-11-17 | 1990-05-17 | John E. Reardon | Chromogenic substrate for esterase and immunoassay using same |
| AU656721B2 (en) | 1989-12-29 | 1995-02-16 | Symex Corp. | Methods for diagnosting human influenza and 4-position modified chromogenic N-acetylneuraminic acid substrates for use therein |
| US5314801A (en) | 1992-11-06 | 1994-05-24 | Becton, Dickinson And Company | Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis |
| US5470723A (en) | 1993-05-05 | 1995-11-28 | Becton, Dickinson And Company | Detection of mycobacteria by multiplex nucleic acid amplification |
| US5457027A (en) | 1993-05-05 | 1995-10-10 | Becton, Dickinson And Company | Internal controls for isothermal nucleic acid amplification reactions |
| US5518884A (en) | 1994-02-28 | 1996-05-21 | Becton, Dickinson And Company | Nucleic acid sequences specific for mycbacterium kansasii |
| US5639428A (en) | 1994-07-19 | 1997-06-17 | Becton Dickinson And Company | Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay |
| US5719020A (en) * | 1996-09-25 | 1998-02-17 | Oklahoma Medical Research Foundation | 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens |
| US6194220B1 (en) | 1996-09-25 | 2001-02-27 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| US5998221A (en) | 1996-09-25 | 1999-12-07 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| NZ335368A (en) | 1996-11-14 | 2001-08-31 | Biota Scient Management | Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase |
| AU1927899A (en) * | 1997-12-18 | 1999-07-05 | Sepracor, Inc. | Screening assays for the detection and diagnosis of influenza virus |
| US6267722B1 (en) | 1998-02-03 | 2001-07-31 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6394952B1 (en) | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| US6303764B1 (en) | 1998-09-24 | 2001-10-16 | Zymetx, Inc. | Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids |
| JP2002541858A (ja) | 1999-04-16 | 2002-12-10 | ザイメテックス インコーポレイテッド | ウイルス由来の酵素および化学発光基質を用いるウイルス検出法 |
| US6420552B1 (en) | 1999-09-10 | 2002-07-16 | Zymetx, Inc. | Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids |
| EP1253203A1 (en) | 2001-04-25 | 2002-10-30 | Becton Dickinson and Company | Rapid resuscitation, growth, capture and detection of microorganisms |
| CA2523016C (en) | 2003-04-25 | 2018-05-15 | Becton, Dickinson And Company | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| US7595152B2 (en) | 2005-07-01 | 2009-09-29 | Arbor Vita Corporation | Detection of influenza virus |
| WO2007053487A2 (en) * | 2005-10-28 | 2007-05-10 | Binax, Inc. | Methods and devices for detection of the strain of a pathogen |
| US8163237B2 (en) | 2006-05-08 | 2012-04-24 | Becton, Dickinson And Company | Vascular access device pathogenic status indication |
| US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
| MX2008014529A (es) | 2006-05-18 | 2009-01-28 | Veterinaermedizinische Uni Wie | Metodo de deteccion para virus de influenza. |
| JP2008014751A (ja) | 2006-07-05 | 2008-01-24 | Denka Seiken Co Ltd | 着色ラテックス粒子を用いるメンブレンアッセイ法およびキット |
| JP5300200B2 (ja) | 2006-08-31 | 2013-09-25 | 大阪府 | トリインフルエンザウイルスに特異的な迅速診断法 |
| US9086408B2 (en) * | 2007-04-30 | 2015-07-21 | Nexus Dx, Inc. | Multianalyte assay |
| US7893272B2 (en) | 2007-05-15 | 2011-02-22 | Cellex, Inc. | Reagents and kits for detection of influenza virus and the like |
| US8163474B2 (en) * | 2008-03-15 | 2012-04-24 | Arbor Vita Corporation | NS1-NP diagnostics of influenza virus infection |
| CA2761733C (en) * | 2009-06-01 | 2019-01-08 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Reagents and methods for detecting influenza virus proteins |
| WO2014165536A1 (en) | 2013-04-01 | 2014-10-09 | Becton, Dickinson And Company | Methods and kits for the diagnosis of influenza |
-
2014
- 2014-04-01 WO PCT/US2014/032567 patent/WO2014165536A1/en not_active Ceased
- 2014-04-01 AU AU2014248225A patent/AU2014248225B2/en active Active
- 2014-04-01 CN CN201480031254.8A patent/CN105264086B/zh active Active
- 2014-04-01 KR KR1020157031383A patent/KR102348484B1/ko not_active Expired - Fee Related
- 2014-04-01 CA CA2908028A patent/CA2908028C/en active Active
- 2014-04-01 ES ES14720452T patent/ES2754402T3/es active Active
- 2014-04-01 JP JP2016506385A patent/JP6591398B2/ja active Active
- 2014-04-01 EP EP14720452.3A patent/EP2981618B1/en active Active
- 2014-04-01 CN CN201810491986.5A patent/CN108663518B/zh active Active
- 2014-04-01 BR BR112015025042-4A patent/BR112015025042B1/pt active IP Right Grant
- 2014-04-01 US US14/781,008 patent/US10317404B2/en active Active
- 2014-04-01 RU RU2015141509A patent/RU2713112C2/ru active
-
2019
- 2019-04-15 US US16/384,020 patent/US11209433B2/en active Active
- 2019-09-18 JP JP2019169472A patent/JP7096219B2/ja active Active
-
2020
- 2020-08-31 AU AU2020227005A patent/AU2020227005B2/en active Active
-
2021
- 2021-11-16 US US17/527,524 patent/US12372525B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102348484B1 (ko) | 2022-01-07 |
| CN108663518A (zh) | 2018-10-16 |
| RU2713112C2 (ru) | 2020-02-03 |
| CA2908028C (en) | 2022-10-18 |
| WO2014165536A1 (en) | 2014-10-09 |
| CA2908028A1 (en) | 2014-10-09 |
| US20190339272A1 (en) | 2019-11-07 |
| AU2020227005A1 (en) | 2020-09-17 |
| KR20160018479A (ko) | 2016-02-17 |
| US20160041167A1 (en) | 2016-02-11 |
| CN105264086A (zh) | 2016-01-20 |
| CN108663518B (zh) | 2022-03-11 |
| RU2015141509A3 (https=) | 2018-03-30 |
| ES2754402T3 (es) | 2020-04-17 |
| AU2020227005B2 (en) | 2022-12-08 |
| AU2014248225A1 (en) | 2015-10-29 |
| WO2014165536A8 (en) | 2016-09-01 |
| BR112015025042A2 (https=) | 2017-09-05 |
| US10317404B2 (en) | 2019-06-11 |
| US11209433B2 (en) | 2021-12-28 |
| JP2019215377A (ja) | 2019-12-19 |
| JP6591398B2 (ja) | 2019-10-16 |
| EP2981618B1 (en) | 2019-08-28 |
| EP2981618A1 (en) | 2016-02-10 |
| CN105264086B (zh) | 2018-06-15 |
| RU2015141509A (ru) | 2017-05-16 |
| AU2014248225B2 (en) | 2020-06-25 |
| JP7096219B2 (ja) | 2022-07-05 |
| US12372525B2 (en) | 2025-07-29 |
| US20220146514A1 (en) | 2022-05-12 |
| JP2016524127A (ja) | 2016-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12372525B2 (en) | Methods and kits for the diagnosis of influenza | |
| LeBlanc et al. | A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2 | |
| Yip et al. | Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection | |
| Song et al. | Single-and two-stage, closed-tube, point-of-care, molecular detection of SARS-CoV-2 | |
| Zou et al. | Rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic Signal amplification system coupled with a lateral flow immunoassay strip | |
| Wang et al. | Detection of respiratory viruses directly from clinical samples using next‐generation sequencing: A literature review of recent advances and potential for routine clinical use | |
| Barreto et al. | Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities | |
| Choudhary et al. | Comparison of the conventional multiplex RT–PCR, real time RT–PCR and Luminex xTAG® RVP fast assay for the detection of respiratory viruses | |
| Verma et al. | Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report | |
| Kato et al. | An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac | |
| Ma et al. | Rapid detection of avian influenza A virus (H7N9) by lateral flow dipstick recombinase polymerase amplification | |
| Biber et al. | The role of mouthwash sampling in SARS-CoV-2 diagnosis | |
| Ganzenmueller et al. | Comparison of the performance of the Panther Fusion respiratory virus panel to R-Gene and laboratory developed tests for diagnostic and hygiene screening specimens from the upper and lower respiratory tract | |
| McHenry et al. | Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry | |
| Mora et al. | A one-pot RT-LAMP diagnostic assay for SARS-CoV-2 from saliva samples | |
| Su et al. | Performance evaluation of influenza a rapid antigen test and PCR among nasopharyngeal and oropharyngeal samples | |
| Meng et al. | Microfluidic measurement of intracellular mRNA with a molecular beacon probe towards point-of-care radiation triage | |
| Kweon et al. | Positivity of rapid antigen testing for SARS-CoV-2 with serial followed-up nasopharyngeal swabs in hospitalized patients due to COVID-19 | |
| US20210349081A1 (en) | Diagnostics method for detecting microparticles | |
| Zhi et al. | Development of rapid nucleic acid testing techniques for common respiratory infectious diseases in the Chinese population | |
| Lin et al. | A biochemiluminescent assay for rapid diagnosis of influenza | |
| Gheyath K et al. | Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter | |
| Baron | Multiple test methods for the detection of novel H1N1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/04/2014, OBSERVADAS AS CONDICOES LEGAIS |